Severe adverse events leading to withdrawal of treatment · bacterial furunculosis
Cefadroxil showed no clear difference in severe adverse events leading to withdrawal of treatment (reported… compared with flucloxacillin (low certainty).
1 finding from 1 review
Minor adverse events not leading to withdrawal of treatment · bacterial furunculosis
Cefadroxil probably leads to lower minor adverse events not leading to withdrawal of treatment… compared with flucloxacillin (moderate certainty).
1 finding from 1 review
Clinical cure · bacterial folliculitis and boils (furuncles and carbuncles)
Cefdinir showed no clear difference in clinical cure (measured 17 to 24 days after treatment) compared with cefalexin (low certainty).
1 finding from 1 review
Severe adverse events leading to withdrawal of treatment · bacterial folliculitis and boils (furuncles and carbuncles)
Cefdinir showed no clear difference in severe adverse events leading to withdrawal of treatment (reported… compared with cefalexin (low certainty).
1 finding from 1 review
Clinical cure · bacterial boils (furuncles and carbuncles)
It is very uncertain whether azithromycin changes clinical cure (measured 7 days after treatment) compared with cefaclor (very low certainty).
1 finding from 1 review
Severe adverse events leading to withdrawal of treatment · bacterial boils (furuncles and carbuncles)
1 finding from 1 review
Minor adverse events not leading to withdrawal of treatment · bacterial boils (furuncles and carbuncles)
It is very uncertain whether azithromycin changes minor adverse events not leading to withdrawal of treatment… compared with cefaclor (very low certainty).
1 finding from 1 review
Clinical cure · bacterial boils (furuncles and carbuncles)
Cefditoren pivoxil showed no clear difference in clinical cure (measured after 7 days of treatment) compared with cefaclor (moderate certainty).
1 finding from 1 review
Severe adverse events leading to withdrawal of treatment · bacterial boils (furuncles and carbuncles)
Cefditoren pivoxil showed no clear difference in severe adverse events leading to withdrawal of treatment (reported… compared with cefaclor (low certainty).
1 finding from 1 review
Minor adverse events not leading to withdrawal of treatment · bacterial boils (furuncles and carbuncles)
Cefditoren pivoxil showed no clear difference in minor adverse events not leading to withdrawal of treatment… compared with cefaclor (moderate certainty).
1 finding from 1 review
Intervention not reported
Transepidermal water loss (TEWL) Measured using temperature‐adjusted g/m²/h with the Tewameter TM 300 (Courage + Khazaka, Cologne, Germany) Hahnel 2017: measured at 56 ± 4 days Shishido 2017: measured 15 minutes after wiping the skin with a dry to... · people 60 years of age and older
1 finding from 1 review
Pruritus · adults with eczema
1 finding from 1 review
Ulcer healing · ulceration caused by nerve damage in leprosy
1 finding from 1 review
Physician's assessment of global response of improvement, clear or excellent ‐ 6 weeks · people with atopic dermatitis
Tacrolimus 0.03% probably leads to higher physician's assessment of global response of improvement, clear or… compared with corticosteroids (moderate certainty).
4 findings from 1 review
RR 2.05 [1.36, 3.08]
1 study · 411 participants
Moderate
RR 2.58 [1.96, 3.38]
2 studies · 790 participants
Moderate
RR 0.45 [0.13, 1.57]
2 studies · 409 participants
Very low
Show 1 more finding
Participant's self‐assessment of global response of improvement: tacrolimus 0.03% 2x/day versus hydrocortisone acetate 1% 2x/day · people with atopic dermatitis
Tacrolimus 0.03% probably leads to higher participant's self‐assessment of global response of improvement:… compared with corticosteroids (moderate certainty).
1 finding from 1 review
Incidence of herpes labialis during use of the preventative intervention (by clinical evaluation) ‐ aciclovir 200 mg 5 times/day · participants with recurrent herpes labialis
Oral aciclovir (short‐term) showed no clear difference in incidence of herpes labialis during use of the preventative… compared with placebo (low certainty).
1 finding from 1 review
Complete cure, at least 3 months after the end of treatment · People with American cutaneous leishmaniasis
Thermotherapy one session (at 50 ºC for 30 seconds) leads to lower complete cure, at least 3 months after the end of treatment compared with meglumine antimoniate (20 mg Sb5/kg/day (high certainty).
1 finding from 1 review
Adverse effects · People with American cutaneous leishmaniasis
1 finding from 1 review
Recurrence ‐ not measured · People with American cutaneous leishmaniasis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participant‐reported improvement of hirsutism ‐ not measured · women with hirsutism
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found